Potentiated 5-hydroxytryptophan response suppression following 5,7-dihydroxytryptamine raphe lesions in an animal model of depression.
Engleman
E A
EA
Department of Psychiatry, Indiana University School of Medicine, Indianapolis.
Hingtgen
J N
JN
Zhou
F C
FC
Murphy
J M
JM
Aprison
M H
MH
D015116:5,7-Dihydroxytryptamine; D000818:Animals; D001143:Arousal / Q000187:drug effects / Q000502:physiology; D003866:Depressive Disorder / Q000139:chemically induced / Q000503:physiopathology*; D005625:Frontal Lobe / Q000187:drug effects / Q000503:physiopathology; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism; D007031:Hypothalamus / Q000187:drug effects / Q000503:physiopathology; D008297:Male; D011903:Raphe Nuclei / Q000187:drug effects / Q000503:physiopathology*; D051381:Rats; D011919:Rats, Inbred Strains; D011985:Receptors, Serotonin / Q000187:drug effects / Q000502:physiology*; D012701:Serotonin / Q000502:physiology*; D013787:Thalamic Nuclei / Q000187:drug effects / Q000503:physiopathology
D011985:Receptors, Serotonin; D015116:5,7-Dihydroxytryptamine; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid